Nine Masts Capital’s Athenahealth, Inc. ATHN Stock Holding History

Nine Masts Capital’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-101	Closed	-$16K	–	406
2018 Q2	$16K	Buy	+101	New	+$15K	﹤0.01%	261
2018 Q1	–	Sell	-1,517	Closed	-$202K	–	402
2017 Q4	$202K	Buy	+1,517	New	+$194K	0.03%	124

Other funds holding ATHN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Nine Masts Capital's ATHN Position: Q3 2018 in Review

Nine Masts Capital sold out of Athenahealth, Inc. (ATHN) in Q3 2018, closing a stake of 101 shares — an estimated $16K sold.

Nine Masts Capital first reported a position in ATHN in Q4 2017 and held it in 2 quarters. The position peaked at $202K in Q4 2017. 276 funds tracked by Wall St. Rank hold ATHN as of Q3 2018.

Nine Masts Capital reported no remaining Athenahealth, Inc. position as of Q3 2018 after selling out during the quarter.
Nine Masts Capital sold 101 Athenahealth, Inc. shares in Q3 2018, an estimated $16K.
Nine Masts Capital first reported a position in Athenahealth, Inc. in Q4 2017 and held it in 2 quarters.
Nine Masts Capital's Athenahealth, Inc. position peaked at $202K in Q4 2017.
276 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q3 2018.

Based on Nine Masts Capital's 13F filing for Q3 2018, filed 16 Nov 2018.